LungLife AI Inc on Thursday said it expects to conclude its clinical validation study for its LungLB test by the end of the fourth quarter of the year.
The California-based developer of clinical.
LungLife AI Inc on Tuesday marked an important interim period, as its revenue more than doubled and its loss narrowed.
LungLife AI is a California-based developer of clinical diagnostic solutions.
LungLife AI Inc on Tuesday said that it has completed enrolment for its prospective validation study of LungLB.
LungLife is a California-based developer of clinical diagnostic solutions designed to. | May 23, 2023
LungLife AI full-year loss widens; revenue plummets lse.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lse.co.uk Daily Mail and Mail on Sunday newspapers.
LungLife AI to be worth GBP45 million on AIM admission next week lse.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lse.co.uk Daily Mail and Mail on Sunday newspapers.